Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pyoderma”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableUnknownNCT04792957
What this trial is testing

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Who this might be right for
Pyoderma GangrenosumHidradenitis SuppurativaPsoriasis
Dokuz Eylul University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444684
What this trial is testing

Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Not applicableWithdrawnNCT05984654
What this trial is testing

Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Ohio State University
Testing effectiveness (Phase 2)Study completedNCT02733094
What this trial is testing

Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Technical University of Munich 8
Large-scale testing (Phase 3)Ended earlyNCT02315417
What this trial is testing

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 16
Testing effectiveness (Phase 2)Ended earlyNCT06092216
What this trial is testing

Spesolimab in Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Icahn School of Medicine at Mount Sinai 5
Very early researchWithdrawnNCT05821374
What this trial is testing

Deucravacitinib in PG

Who this might be right for
Pyoderma Gangrenosum
Dartmouth-Hitchcock Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06624670
What this trial is testing

Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Boehringer Ingelheim 90
Testing effectiveness (Phase 2)UnknownNCT05890703
What this trial is testing

Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream

Who this might be right for
Ulcus CrurisEcthymaUlcer, Leg+1 more
Juerg Hafner 40
Testing effectiveness (Phase 2)WithdrawnNCT00730717
What this trial is testing

Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wright State University
Not applicableStudy completedNCT00791557
What this trial is testing

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Who this might be right for
Pyoderma GangrenosumCrohn's DiseaseUlcerative Colitis+1 more
University Hospitals Cleveland Medical Center 2
Large-scale testing (Phase 3)Ended earlyNCT02318914
What this trial is testing

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 15
Testing effectiveness (Phase 2)WithdrawnNCT00690846
What this trial is testing

Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Ended earlyNCT05964413
What this trial is testing

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
InflaRx GmbH 54
Not applicableStudy completedNCT00436891
What this trial is testing

Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji

Who this might be right for
Streptococcus Group A
National Institute of Allergy and Infectious Diseases (NIAID) 550
Testing effectiveness (Phase 2)Study completedNCT03137160
What this trial is testing

An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Ohio State University 4
Post-approval studies (Phase 4)Ended earlyNCT05120726
What this trial is testing

A Novel Therapeutic Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Louisiana State University Health Sciences Center in New Orleans 5
Not applicableUnknownNCT03636737
What this trial is testing

Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Assistance Publique Hopitaux De Marseille 140
Testing effectiveness (Phase 2)WithdrawnNCT04274166
What this trial is testing

Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Ended earlyNCT05343754
What this trial is testing

Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Erasmus Medical Center 3
Load More Results